PICTON MAHONEY ASSET MANAGEMENT - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 187 filers reported holding REVANCE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.

Quarter-by-quarter ownership
PICTON MAHONEY ASSET MANAGEMENT ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$3,403
-18.3%
134,388
+3.9%
0.15%
-20.5%
Q1 2023$4,167
+126.0%
129,355
+29.4%
0.18%
+112.6%
Q4 2022$1,844
-99.9%
99,980
+62.8%
0.09%
+45.0%
Q3 2022$1,660,00061,4000.06%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 4,592,047$156,130,00032.47%
Camber Capital Management LP 630,000$21,420,0001.40%
Granite Point Capital Management, L.P. 50,000$1,700,0001.17%
Rhenman & Partners Asset Management AB 82,000$2,788,0000.83%
Geduld E E 25,001$850,0000.53%
Pier Capital, LLC 106,985$3,637,0000.52%
Ghost Tree Capital, LLC 20,000$680,0000.48%
ArrowMark Colorado Holdings LLC 433,457$14,738,0000.42%
Polar Capital LLP 577,042$19,618,0000.42%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 256,500$8,721,0000.35%
View complete list of REVANCE THERAPEUTICS INC shareholders